HCA - HCA Healthcare, Inc.

HCA

$371.18 14.56 (-3.77%) Last updated: Jul 19, 2026 19:20

52-Week Range

$371.18

$330.00 $371.18 $556.52

Fundamentals Overview

HCA Healthcare, Inc. is near the low of its 52-week range with attractive valuation, trending downward today.

Valuation attractive

P/E 12.4 PEG 0.7 P/S 1.08

Intrinsic value (DCF)

-2.1% downside vs price

Profitability

Net margin 8.9%

Risk (Beta)

1.13 — in line vol

Earnings & growth

EPS $29.98 Rev -2.1% Profit -13.7% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Hold — 55% confidence Risk: Moderate Volatility — Beta 1.13. Diversify and only invest what you can afford to lose.

Supporting (Buy):

Analyst grade: B-

Pressures (Sell):

Sentiment weakening (1 downgrade) · 3M vs S&P 500: -30.2% · 3M vs Healthcare sector: -33%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

$82.34B

P/E (TTM)

12.38

EPS (TTM)

$29.98

Dividend Yield

0.81%

52-Week Range

$330.00 - $556.52

Volume vs Avg

N/A

Beta

1.13

About

HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care, cardiac treatment, diagnostic procedures, and emergency services. These hospitals additionally offer a broad range of outpatient care, such as ambulatory surgery, laboratory testi...

Sector: Healthcare

Headquarters: US

Employees: 320,000

IPO Date: Mar 2011

Website: www.hcahealthcare.com

Beta: 1.13 (More volatile than market)

Ratings & Grades at a Glance

Overall rating: B-. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 10, Equal Weight: 5, Market Perform: 1, Neutral: 1, Outperform: 6, Overweight: 7.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $363.40; current price is $371.18. That’s a -2.1% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric	Value
Valuation
P/E (TTM)	12.38
DCF value (model)	$363.40 (-2.1% vs price)
PEG (TTM)	0.7
P/B (TTM)	N/A
P/S (TTM)	1.08
P/FCF (TTM)	10.39
Liquidity & enterprise
Current Ratio (TTM)	0.83
Quick Ratio (TTM)	0.75
Cash Ratio (TTM)	0.05
Profitability
ROE (TTM)	N/A
ROA (TTM)	N/A
Revenue growth (YoY)	N/A
Net margin (TTM)	8.89%
Gross margin (TTM)	34.92%
Operating margin (TTM)	15.67%
Debt to equity (TTM)	N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for HCA.

Analyst Sentiment at a Glance

B- Sentiment Weakening

Buy 10Equal Weight 5Market Perform 1Neutral 1Outperform 6Overweight 7

0 upgrades, 1 downgrade

Price Target Consensus

Current $371.18

Median $510.00

Consensus $486.85

Low consensus $402.00

High consensus $635.00

Stock Grades (Institutions)

Institution	Action	Previous Grade	New Grade	Date
Barclays	maintain	Equal Weight	Equal Weight	2026-07-16
RBC Capital	maintain	Outperform	Outperform	2026-07-15
Keybanc	maintain	Overweight	Overweight	2026-07-14
Wells Fargo	maintain	Equal Weight	Equal Weight	2026-07-13
Barclays	downgrade	Overweight	Equal Weight	2026-07-08
Cantor Fitzgerald	maintain	Overweight	Overweight	2026-07-07
TD Cowen	maintain	Buy	Buy	2026-06-22
Bernstein	maintain	Market Perform	Market Perform	2026-06-04
Truist Securities	maintain	Buy	Buy	2026-04-27
Oppenheimer	maintain	Outperform	Outperform	2026-04-27
Stephens & Co.	maintain	Overweight	Overweight	2026-04-27
Keybanc	maintain	Overweight	Overweight	2026-04-27
Barclays	maintain	Overweight	Overweight	2026-04-27
RBC Capital	maintain	Outperform	Outperform	2026-04-27
Wells Fargo	maintain	Equal Weight	Equal Weight	2026-04-27
TD Cowen	maintain	Buy	Buy	2026-04-27
TD Cowen	maintain	Buy	Buy	2026-03-10
Mizuho	maintain	Outperform	Outperform	2026-02-25
UBS	maintain	Buy	Buy	2026-02-23
JP Morgan	maintain	Neutral	Neutral	2026-02-20
Argus Research	maintain	Buy	Buy	2026-02-06
Wells Fargo	maintain	Equal Weight	Equal Weight	2026-01-30
Oppenheimer	maintain	Outperform	Outperform	2026-01-28
Keybanc	maintain	Overweight	Overweight	2026-01-28
Deutsche Bank	maintain	Buy	Buy	2026-01-28
Barclays	maintain	Overweight	Overweight	2026-01-28
Jefferies	maintain	Buy	Buy	2026-01-28
UBS	maintain	Buy	Buy	2026-01-28
Truist Securities	maintain	Buy	Buy	2026-01-28
RBC Capital	maintain	Outperform	Outperform	2026-01-28